CONFIDENTIAL Patrick McEnany Chief Executive Officer Catalyst Pharmaceutical Partners, Inc. 355 Alhambra Circle, Suite 1370 Coral Gables, FL 33134 Dear Mr. McEnany:Placement Agent Agreement • September 12th, 2008 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • New York
This letter (the “Agreement”) constitutes the agreement between Rodman & Renshaw, LLC (“Rodman” or the “Placement Agent”) and Catalyst Pharmaceutical Partners, Inc. (the “Company”), that Rodman shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of registered securities (the “Securities”) of the Company, including shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The terms of such Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that Rodman would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 12th, 2008 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 11, 2008, between Catalyst Pharmaceutical Partners, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
